Jbog, if they didn't put any value to 788, could they have been allowed to sell the patent of 788 to another party to recover the expenses they spent on that drug after all they considered it for an unmet medical need? Or did they see something in that drug that it's not going to take off anyway?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.